← Eichor
Study identifier: NCT06862102 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Multiple Human Papillomavirus Infections in the Development of CIN

Condition: CIN - Cervical Intraepithelial Neoplasia · HPV · HPV Vaccines  ·  Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia

PhaseN/A
Planned participants152
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Multiple infections of high-risk genotypes of Human Papillomavirus (HR-HPV) in patients with abnormal cervical cytological or histological findings are detectable in a percentage ranging from 20% to 50% of cases. Some studies have detected a certain tendency to specific clustering in multiple infections, both inter-species and inter-genotypic, such as HPV 31-35-56, HPV 16-51-52, HPV 16-18, HPV 51-52. Furthermore, a greater tendency of the HPV16 genotype to cluster with genotypes of different species is reported in the literature. However, other studies claim a random character of such genotypic associations in multiple infections. This heterogeneity of results of the studies present in the literature underlies multiple factors, both epidemiological and methodological, implicated in the high variability of prevalence and diagnostic findings of multiple infections. In particular, with regard to epidemiological characteristics, factors influencing the distribution of multiple infections appear to be the origin and type of population, economic-social status, young age, HIV seropositivity and recent sexual activity. A further hypothesized element is represented by a possible individual susceptibility dictated by the immune profile of the host towards specific genotypes, potentially facilitating the occurrence of co-infections by these, possibly resulting in a synergistic effect on the oncogenic potential. From a clinical point of view, to date multiple cross-sectional studies sug…

This description comes directly from the study's public registry record.

Talk to the study team

Barbara Gardella, Principal investigator  ·  +390382503720  ·  b.gardella@smatteo.pv.it

Always discuss trial participation with your own doctor first.

Locations (1)

Fondazione IRCCS Policlinico San Matteo, SC Ostetricia e Ginecologia 1Pavia, Pavia, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06862102